Literature DB >> 33371296

Therapeutic Potential of Rhododendron arboreum Polysaccharides in an Animal Model of Lipopolysaccharide-Inflicted Oxidative Stress and Systemic Inflammation.

Ajaz Ahmad1, Adil Farooq Wali2, Muneeb U Rehman1, Andleeb Khan3, Mohammad Raish4, Mohsin Kazi4, Osamah Alnemer4, Padma G M Rao5.   

Abstract

Systemic inflammation results in physiological changes, largely mediated by inflammatory cytokines. The present investigation was performed to determine the effect of Rhododendron arboreum (RAP) on inflammatory parameters in the animal model. The RAP (100 and 200 mg/kg) were pre-treated for animals, given orally for one week, followed by lipopolysaccharide (LPS) injection. Body temperature, burrowing, and open field behavioral changes were assessed. Biochemical parameters (AST, ALT, LDH, BIL, CK, Cr, BUN, and albumin) were done in the plasma after 6 h of LPS challenge. Oxidative stress markers SOD, CAT, and MDA were measured in different organs. Levels of inflammatory markers like tumor necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1β) and, interleukin-6 (IL-6) as well as VEGF, a specific sepsis marker in plasma, were quantified. The plasma enzymes, antioxidant markers and plasma pro-inflammatory cytokines were significantly restored (p < 0.5) by RAP treatment, thus preventing the multi-organ and tissue damage in LPS induced rats. The protective effect of RAP may be due to its potent antioxidant potential. Thus, RAP can prevent LPS induced oxidative stress, as well as inflammatory and multi-organ damage as reported in histopathological studies in rats when administered to the LPS treated animals. These findings indicate that RAP can benefit in the management of systemic inflammation from LPS and may have implications for a new treatment or preventive therapeutic strategies with an inflammatory component.

Entities:  

Keywords:  Rhododendron arboreum polysaccharides; animal model; lipopolysaccharide; multi-biomarker approach; oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 33371296      PMCID: PMC7767231          DOI: 10.3390/molecules25246045

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  43 in total

1.  Inflammation 2010: new adventures of an old flame.

Authors:  Ruslan Medzhitov
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.

Authors:  Norbert F Voelkel; Carlyne Cool; Laima Taraceviene-Stewart; Mark W Geraci; Michael Yeager; Todd Bull; Michael Kasper; Rubin M Tuder
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

Review 4.  The pathogenesis of sepsis.

Authors:  Deborah J Stearns-Kurosawa; Marcin F Osuchowski; Catherine Valentine; Shinichiro Kurosawa; Daniel G Remick
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 5.  Chronic inflammation and immunologic-based constraints in malignant disease.

Authors:  Devin B Lowe; Walter J Storkus
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

Review 6.  IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

Authors:  Katsuhiko Ishihara; Toshio Hirano
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

Review 7.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 8.  Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.

Authors:  Wibke Schulte; Jürgen Bernhagen; Richard Bucala
Journal:  Mediators Inflamm       Date:  2013-06-18       Impact factor: 4.711

Review 9.  Macrophage cytokines: involvement in immunity and infectious diseases.

Authors:  Guillermo Arango Duque; Albert Descoteaux
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

10.  Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone.

Authors:  Ting-Yun Chuang; An-Jie Cheng; I-Ting Chen; Tien-Yun Lan; I-Hsuan Huang; Chung-Wai Shiau; Chia-Lin Hsu; Ya-Wen Liu; Zee-Fen Chang; Ping-Hui Tseng; Jean-Cheng Kuo
Journal:  Oncotarget       Date:  2017-07-25
View more
  2 in total

1.  Mechanism of Anti-Inflammatory and Antibacterial Effects of QingXiaoWuWei Decoction Based on Network Pharmacology, Molecular Docking and In Vitro Experiments.

Authors:  Qian Zhang; Xue Li; Jun Li; Yuxia Hu; Jing Liu; Fang Wang; Wei Zhang; Fuhou Chang
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

2.  Effects of Dietary Ferulic Acid Supplementation on Hepatic Injuries in Tianfu Broilers Challenged with Lipopolysaccharide.

Authors:  Gang Shu; Ziting Tang; Hong Du; Yilei Zheng; Lijen Chang; Haohuan Li; Funeng Xu; Hualin Fu; Wei Zhang; Juchun Lin
Journal:  Toxins (Basel)       Date:  2022-03-21       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.